Applied DNA Sciences, Inc.

NasdaqCM:APDN Stock Report

Market Cap: US$3.5m

Applied DNA Sciences Balance Sheet Health

Financial Health criteria checks 6/6

Applied DNA Sciences has a total shareholder equity of $4.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $9.9M and $5.8M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$3.36m
EquityUS$4.13m
Total liabilitiesUS$5.78m
Total assetsUS$9.91m

Recent financial health updates

Recent updates

The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%

Dec 20
The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%

Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?

Jan 01
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?

Applied DNA climbs 51% after winning large purchase order

Oct 10

Applied DNA stock rises 12% on launching monkeypox testing service in New York

Sep 06

Applied DNA adds 17% as company seeks approval for monkeypox test in New York

Aug 19

Upgrade: Analysts Just Made A Notable Increase To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts

Aug 17
Upgrade: Analysts Just Made A Notable Increase To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts

Applied DNA Sciences gains as it secures ~$3.6M proceeds from warrant exercise

Aug 09

Applied DNA stock soars 73% on starting validation of PCR-based monkeypox test

Aug 02

Applied DNA announces positive data from veterinary vaccine trial to treat COVID-19

Jul 25

News Flash: Analysts Just Made A Notable Upgrade To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts

May 18
News Flash: Analysts Just Made A Notable Upgrade To Their Applied DNA Sciences, Inc. (NASDAQ:APDN) Forecasts

Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Deliver On Growth Plans?

Sep 17
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Deliver On Growth Plans?

Applied DNA's LinearDNA COVID-19 vaccine booster yields 5-fold increase in neutralizing antibody in felines

May 06

Financial Position Analysis

Short Term Liabilities: APDN's short term assets ($4.6M) exceed its short term liabilities ($2.6M).

Long Term Liabilities: APDN's short term assets ($4.6M) exceed its long term liabilities ($3.2M).


Debt to Equity History and Analysis

Debt Level: APDN is debt free.

Reducing Debt: APDN has no debt compared to 5 years ago when its debt to equity ratio was 279.5%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: APDN has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: APDN is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.